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Summary.-The mechanisms of non-specific resistance to syngeneic methyl-
cholanthrene-induced fibrosarcomas of mice were investigated. Results showed
that a small tumour graft of 0*05 x 105 cells is greatly enhanced in growth when ad-
mixed with large numbers of cell fragments, killed cells or viable non-replicating
cells. The enhancement of small tumour grafts in cell mixtures was found to be
non-specific.
Carrageenan, a known anti-macrophage agent, significantly increased tumour
growth in normal mice. However, it did not enhance the increased tumour growth of
0 05 x 105 cells mixed with 106 viable, non-replicating mitomycin C-treated tumour
cells. The latter observation indicates that carrageenan and admixed cells interfere
with the same tumour-inhibitory mechanism and therefore cannot produce additive
effects. The results give support to the concept of a non-specific macrophage "sur-
veillance" system which appears crucial in controlling tumour growth, since it
determines the establishment of small numbers of tumour cells while they can still
be easily destroyed.
THE BEHAVIOUR and fate of small
numbers of tumour cells have been a
matter of considerable interest and specu-
lation. Some tumours are capable of
immediate growth by experimental inocu-
lation or transplantation of a single cell
(Furth & Kahn, 1937). Others fail to
grow under similar circumstances and
require relatively more cells before a
tumour "take" occurs. Fisher & Fisher
(1963) showed that an inoculum of a
transplantable tumour, insufficientinnum-
bers to produce growth, can start multi-
plication weeks later if some stimulus
such as laparotomy, or an injection of
tissue homogenate at the same implanta-
tion site is given. Reve'sz (1958) found that
in genetically compatible tumour-host
systems, cells irreversibly damaged by
heavy doses of radiation exert a profound
enhancing influence on the growth of
admixed viable cells. In subsequent ex-
periments, Revesz (1958) showed that
the growth stimulation by irradiated cells
of small numbers of viable cells failed to
occur if the 2 populations were separ-
ated.
Recently, the concept of non-specific
immune surveillance has been suggested
as an important mechanism in the control
of tumours (Alexander, 1976).
The following investigation was under-
taken to determine whether carrageenan,
a product of marine algae selectively
cytotoxic for macrophages (Allison et al.,
1966; Schwartz & Leskowitz, 1969; Catan-
zaro et al., 1971), would cause the estab-
lishment of small numbers of viable
tumour cells which would not normally
grow. Carrageenan is known to impair
delayed hypersensitivity reactions in vivo
(Bice et al., 1971; Schwartz & Leskowitz,
1969) and is a potent immunosuppressant
ofantibody formation (Aschheim & Raffel,
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1972; Thomson et al., 1976). Keller (1976)
and Thomson & Fowler (1977) have
shown that carrageenan has an enhancing
effect on the growth of relatively large
tumour-cell inocula. Benjamini et al.
(1977) reported that mitomycin C treat-
ment of syngeneic tumour cells prevented
replication of such cells, which could still
be used to induce specific cell-mediated
immunity. The following study involved
mitomycin C-treated syngeneic fibrosar-
coma cells as a source of non-replicating
cells, to see whether they would cause
the establishment of small numbers of
tumour cells in mixtures and, if so, to
determine whether such growth was
enhanced by carrageenan.
MATERIALS AND METHODS
Animals.-Male mice (8-10 weeks old) of
the highly inbred CBA/H/WEHI strain were
used. Their origin and maintenance have
been discussed previously (Basten et at.,
1974).
Tumours.-Two syngeneic methylcholan-
threne-induced fibrosarcomas designated H-I
and H-2 were used. Tumour-cell suspensions
were prepared from solid tumours by pronase
treatment (Kearney & Nelson, 1973). Viable
tumour cells or mixtures in a total volume of
0-2 ml Dulbecco-modified Eagle's medium
(DME), were injected s.c. along the midline
of the abdominal wall. Tumour growth was
expressed as the average tumour diameter
(in units of 0-1 mm) by measuring, at daily
intervals after the 4th day, the smallest and
largest diameters with a Schnelltaster dial
gauge as described previously (Kearney &
Nelson, 1973), or by vernier calipers. The
values given in the text are corrected for the
average thickness of the uninjected-mouse
skin-fold of the abdominal wall.
Preparation of mitomycin C-treated tumour
cells (MCT).-Tumour cells obtained by
incubation with 0.10% pronase in DME
medium were washed x3 in DME medium
with 20% foetal calf serum (FCS). Mitomycin
C (MC; Kyowa Hakko Kogyo Co. Ltd,
Japan) was dissolved in DME medium with
20% FCS and then added to the tumour cells
at a concentration of 30 jug/106 H-I tumour
cells/ml medium. The cells were incubated
at 37°C for 35 min and washed x 3 in mediurn
alone to remove free MC and FCS.
Preparation of other inactivated cells.-
A single-cell suspension of untreated tumour
cells wasprepared asdescribed, andsuspended
to a concentration of 2 x 106 cells in 0-2 ml
of DME medium alone.
For heat treatment, this suspension was
incubated at 56°C for 35 min. This treatment
destroyed the viability of the tumour cells,
as indicated by the trypan-blue exclusion
test.
For freeze-thawing, the suspension was
immersed in liquid N2 and thawed under
running tapwater. The procedure was re-
peated x 3. Viability of the cells was totally
destroyed as assessed by trypan-blue exclu-
sion.
Latex particles.-Calibration latex (Coulter
Electronics, Hertfordshire) of diameter 2-03
,um was washed x 3 by centrifugation, in
medium alone, before use.
Preparation of mixtures of inactivated cells
or particles with tumour ceils.-A single-cell
suspension of untreated H-1 tumour cells
containing 0-1 x 105 cells/0*2 ml was pre-
pared. This suspension was mixed in vitro
with suspensions of MC-treated cells, heat-
killed cells, frozen-thawed cells or latex
particles containing the equivalent of 2 x 106
tumour eells per 0-2 ml. For this purpose, it
was calculated that latex particles were 1
the diameter of the average tumour cell and
that therefore an equivalent volume to 2 x 106
cells would be provided by 2 x 108 latex
particles.
These mixtures in a volume of 0-2 ml were
immediately injected s.c. into the midline
of the abdominal wall of normal mice. There-
fore, each animal received 0 05 x 105 live
H-1 cells mixed with an equivalent of 106
inactivated cells, or 108 latex particles.
Carrageenan.-Lambda carrageenan (Ma-
rine Colloids Inc., Springfield, New Jersey)
was dissolved in boiling physiological saline
at a concentration of 0 5 mg/0-2 ml, and
then stored at -20°C until required. The
method of carrageenan pretreatment was as
follows: animals were given 0 5 mg of
carrageenan, injected i.p., on each of 3 days
before the test procedure, i.e., before the
inoculation of viable cells or admixtures; on
the day of the experiment, a final dose of
0-5 mg was administered, about 1 h before
the tumour-cell inoculation: thus a total of
2 mg was administered in 4 divided doses.
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RESULTS
Admixture of 0 05 x 105 H-1 cells with
106 MC-treated tumour cells
Fig. 1 and Tables I, II and III show
that, whereas a graft of 0 05 x 105 H-1
cells alone produces a tumour in a small
minority ofnormal mice, the same number
of cells, mixed with 106 viable non-
replicating MCT cells, will produce a
tumour inallnormalanimals. Theresultant
tumours grow at a rate comparable to
a dose of 0-5 x 105-H-1 cells given alone
(Fig. 1). The enhancement of a low dose
of H-I tumour cells is also seen when
these cells are admixed with 106 MC-
treated H-2 tumour cells. As seen in
Fig. 1, the growth of 0 05 x 105 H-1 cells
mixed with either 106 MCT-H-1 or 106
MCT-H-2 cells is very similar.
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FIG.41-Effect of admixture of 106 MCT H-1
or MCT H-2 with 0 05 x 105 H-1 tumour
cells inoculated s.c.: 0, 0 05 x 105 H-I
alone; *, 106 MCT H-1 alone; *-,
0 05xI05 H-1+106 MCT H-1; O, 106
MCT H-2 alone; LZ---Li1, O05x105 H-1
+106 MCT H-2; 0 0, 0-5x105 H-1
alone.
Effect of carrageenan pretreatment on the
growth of H-1 tumour cells either alone or
in mixtures
The effect of carrageenan pretreatment
on the growth of a small graft (0.05 x
105 H-1 cells) mixed with 106 MCT-H-1
cells is shown in Fig. 2.
Although carrageenan pretreatment sig-
TABLE I.-Effect of admixture of mito-
mycin C-treated tumour cells (MCT) to
untreated tumour cells
Number of live
untreated H-I
tumour cells
(x 105)
0 05
0-5
0 05
0 05
15
14
13
12
11
10
9
8
7
6
5
4
3
106 MCT
cells
added
H-i
H-2
H-i
H-2
Tumour
incidence
at Day 15
:3/7
7/7
0/8
0/8
8/8
8/8
4 5 6 7 8 9 10 11 12 13 14 15
DAYS AFTER INJECTION
FI(GF. 2 Effect of carrageenan on growth
of admixed MCT H-1 and untreated H-1
tumour cells * *, 106 MCT H-1 alone;
O O, 0 05x 105 H-1 alone; *l---f,
0 05x105H-1+106 MCT H-1; A--- A,
0 05x 105 H-l+carrageenan; CD n, 0 05
x 105 H-1+106 MCT H-i+carrageenan;
* 0 , 05x 105 H-1 alone; A---, 0 5
x 105 H-I+carrageenan.
nificantly enhanced the growth of 0-5 x
105 cells and caused a 100% take of
0 05 x 105 H-1 cells, it did not affect the
growth rate of 0 05x 105 H-1 cells in
mixtures.
Effect of admixture of killed cells
In Table II it can be seen that mixture
with 106 heat-killed or freeze-thawed
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cells also produced enhancement of 0 05 x
105 H-1 cells. However, the resultant
enhancement is not as pronounced as that
seen when MCT cells are used (Fig. 3).
However, if latex particles are mixed
with such a graft, tumour growth is
totally prevented. This also occurred
with a large, optimal dose of tumour
cells, so that it is probable that the latex
particles were toxic for the cells. A violent
inflammatory reaction was seen to occur
at the site of injection of latex particles,
followed by considerable local ulceration.
TABLE II.-Effect of admixture of killed
cells and latex on tumour growth
Inoculum
live H-1
tumour
cells
(X 105)
0-05
0-5
0-05
005
005
005
0-5
0-5
10
9
:- M
ui 8
.s ,E
-
u!E
=> +I
,E CZ: O
4
3
2
No. ofadmixed
cells or latex
particles
106 MCT H-1
106 Heat-killed H-1
106 Frozen-thawed H-1
i08 Latex
106 Frozen-thawed H-1
108 Latex
Tumour
incidence
at
Day 20
4/8
8/8
8/8
8/8
7/8
0/8
8/8
1/8
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FIG. 3-Effect of admixture of either MCT
H-1 cells or dead cells with 0-05 x 105 H-I
cells:- *, 0-05x 105H-I cells+ 106 MCT
H-1 cells; A-A, 0-05 x 105 H-1 cells+ 106
frozen-thawed H- I cells; A-A, 0-05 x 105
H-1 cells+ 106 heat-killed H-I cells.
No growth (not shown) of either 106 MCT
H-1 or 005 x 105 H-1 cells (as in Figs. 1
and 2).
Effect of inoculating MC-treated tumour
cells at a site distantfrom a small live graft
A dose of 0-05 x 105 untreated H-1 cells
was inoculated s.c. into normal mice.
At the same time, 106 MCT-H-1 or
MCT-H-2 cells were inoculated i.p. Table
III shows that MCT cells separated from
the small graft did not promote tumour
enhancement as seen with mixtures.
TABLE III.-Effect of mitomycin C-treated
tumour cells (MCT) given i.p., on the
growth of a small tumour graft given s.c.
Cells
given
Cells
given
i.p. S.C.
- 106 MCT H-1
106 MCT H-1
+0-05 x 105 H-i
- 0.05 x 105 H-1
106 MCT H-1 0 05 x 105 H-1
106 MCT H-2
106 MCT H-2
+0.05x 105 H-1
106 MCT H-2 0.05x 105 H-I
Tumour
incidence
at Day 20
0/7
8/8
1/7
2/8
0/7
8/8
1/8
DISCUSSION
These experiments demonstrate that
a small tumour graft is greatly enhanced
in growth when mixed with large numbers
of inactivated tumour cells. The same
effect results whether or not cells of the
same antigenicity are used (H-1 and H-2
tumours do not cross-react antigenically;
Wu & Kearney, submitted for publica-
tion) and is not dependent on the viability
of the added cells. However, the 2 cell
populations must be mixed, as a simul-
taneous injection of inactivated cells and
a small graft at 2 different sites does
not produce the effect.
Using lethally irradiated cells, Revesz
(1958) observed the same effect. His
results were confirmed and extended by
Toda et al. (1967), Yatvin et al. (1970)
and Hewitt et al. (1973). The explanation
which best fits existing data is that the
admixed tumour cells interfere with a
local, non-specific clearance mechanism
which can normally remove small numbers
of injected cells.
The existence ofamacrophage-mediated
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tumour-inhibitory mechanism was indi-
cated by the enhancement of tumour
growth by the administration of carra-
geenan. This observation has been pre-
viously reported for both chemically
induced (Keller, 1976; Nelson & Nelson,
1978) and virally induced (Lotzova &
Richie, 1977) tumours.
It is unlikely that the enhancement is
due to a direct stimulatory effect of
carrageenan on tumour growth, since
carrageenan has been shown to be toxic
for tumour cells in vitro (Pollack &
Nelson, 1973), although products from
damaged macrophages may have an
enhancing effect (Keller, 1976). Carra-
geenan has many biological effects (Di
Rosa, 1972) including anticoagulant acti-
vity (Anderson & Duncan, 1965) and
inhibition of complement (Borsos et al.,
1965), all of which may affect tumour
growth. However, the most likely ex-
planation for the enhancement is that it
is due to inhibition of macrophage ftunc-
tion. Further evidence for this belief is
found in the report of Keller (1976), who
showed that poly-vinyl-pyridine-N-oxide
(PVNO) could prevent the enhancement
of tumour growth by both carrageenan
and silica. PVNO selectively reverses the
toxic effects of these agents on macro-
phages.
If carrageenan is enhancing tumour
growth in normal animals by crippling
macrophage function, 2 possible mech-
anisms should be considered:
Firstly, it is conceivable that carra-
geenan may have prevented the develop-
ment of specific immunity which normally
restrains tumour growth. This is unlikely,
since tumour growth has already begun
before specific immunity Nwould be expec-
ted to have an effect. Also, in view of
the lack of effect of carrageenan on the
induction and expression of specific im-
munity by MCT cells (Wu & Kearney,
submitted for publication), it is unlikelv
that such a mechanism is responsible for
the observed enhancement.
A second, more plausible, explanation
is that carrageenan pretreatment inter-
feres with a non-specific, macrophage-
mediated, tumour-inhibitory system which
is important in clearing small numbers
of tumour cells in animals without
specific immunity. This mechanism may
mediate a primitive surveillance system
which can recognize and dispose of small
numbers of neoplasite cells, thus pre-
venting the development of small grafts
but only able to reduce the growth poten-
tial of larger grafts.
In the context of the present experi-
ments, it could be postulated that ad-
mixed inactivated tumour cells could
protect small numbers of live cells by
providing macrophages with an over-
whelming load to handle. Thus the potent
cells could escape destruction, while the
macrophages were preoccupied with re-
moving harmless, inactivated or dead
cells. The observation that carrageenan
neither increased nor decreased the effect
may be an indication that both carra-
geenan and admixed cells interfere with
the same tumour-inhibitory mechanism
and therefore cannot produce additive
effects.
In summary these findings, together
with the observation that carrageenan
greatly enhances tumour growth, lend
some support to the concept that a non-
specific, macrophage-mediated "surveil-
lance" system may be as important as
specific immunity in determining the
growth of syngeneic tumours. Because of
the weakness of specific H-1 tumour
immunity (Wu & Kearney, submitted for
publication), it could be argued that, in
this instance, the non-specific mechanism
is crucial in controlling tumour growth,
since it prevents the establishment of
small numbers of tumour cells while they
are still capable of being easily controlled.
However, this concept does not negate
the importance of specific immune mech-
anisms, which may be decisive in limiting
the growth of an established and growing
tumour.
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